FNY Managed Accounts’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-5,580
Closed -$395K 194
2016
Q3
$395K Buy
+5,580
New +$407K 0.33% 54
2015
Q1
Sell
-558
Closed -$46.3K 404
2014
Q4
$46.3K Buy
+558
New +$46.3K 0.05% 125

Other funds holding NVS

FNY Managed Accounts's NVS Position: Q4 2016 in Review

FNY Managed Accounts sold out of Novartis (NVS) in Q4 2016, closing a stake of 5,580 shares — an estimated $395K sold.

FNY Managed Accounts first reported a position in NVS in Q4 2014 and held it in 2 quarters. The position peaked at $395K in Q3 2016. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

  • FNY Managed Accounts reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
  • FNY Managed Accounts sold 5,580 Novartis shares in Q4 2016, an estimated $395K.
  • FNY Managed Accounts first reported a position in Novartis in Q4 2014 and held it in 2 quarters.
  • FNY Managed Accounts's Novartis position peaked at $395K in Q3 2016.
  • 904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on FNY Managed Accounts's 13F filing for Q4 2016, filed 8 Feb 2017.